Ointment for treating empyrosis

A technology of ointment and raw materials, which is applied in the directions of ointment delivery, drug combination, and pharmaceutical formulation, can solve the problems of long treatment course, difficult scarring, and unsatisfactory curative effect, and achieves the effect of convenient use and good swelling effect.

Inactive Publication Date: 2014-07-02
谭小毛
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the medicines for treating burns and scalds on the market include dressings, liquids, ointments, etc., but most of the medicines have unsatisfactory curative effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] Embodiment 1, a kind of ointment for the treatment of burns and scalds, each raw material component: 20 parts of rhubarb, 20 parts of LMZ, 10 parts of safflower, 10 parts of Digupi, 5 parts of glycerin, 5 parts of borneol, 50 parts of medical vaseline share. Add rhubarb, double-sided needles, safflower, and Digupi to soak for a day, add ice flakes, and boil twice in a heating container for three hours each time. Combine the two medicinal liquids and filter to remove residues. The water is evaporated in the evaporator to obtain a paste for use. Then heat the medical vaseline to 50 degrees in the container, add the above-mentioned paste and glycerin successively, mix and stir, stop heating at last, and become an ointment after cooling.

Embodiment 2

[0011] Embodiment 2, a kind of ointment for the treatment of burns and scalds, said raw material components: 30 parts of rhubarb, 30 parts of LMZ, 15 parts of safflower, 15 parts of Digupi, 7.5 parts of glycerin, 7.5 parts of borneol, 65 parts of medical vaseline share. Add rhubarb, double-sided needles, safflower, and Digupi to soak for a day, add ice flakes, and boil twice in a heating container for three hours each time. Combine the two medicinal liquids and filter to remove residues. The water is evaporated in the evaporator to obtain a paste for use. Then heat the medical vaseline to 50 degrees in the container, add the above-mentioned paste and glycerin successively, mix and stir, stop heating at last, and become an ointment after cooling.

Embodiment 3

[0012] Embodiment 3, a kind of ointment for the treatment of burns and scalds, said raw material components: 40 parts of rhubarb, 40 parts of LMZ, 20 parts of safflower, 20 parts of Digupi, 10 parts of glycerin, 10 parts of borneol, 80 parts of medical vaseline share. Add rhubarb, double-sided needles, safflower, and Digupi to soak for a day, add ice flakes, and boil twice in a heating container for three hours each time. Combine the two medicinal liquids and filter to remove residues. The water is evaporated in the evaporator to obtain a paste for use. Then heat the medical vaseline to 50 degrees in the container, add the above-mentioned paste and glycerin successively, mix and stir, stop heating at last, and become an ointment after cooling.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of medicines and specifically relates to an ointment for treating empyrosis. The ointment comprises compositions: 20-40 parts of rheum officinale, 20-40 parts of zanthoxylum nitidum, 10-20 parts of carthamus tinctorius, 10-20 parts of cortex lycii, 5-10 parts of glycerin, 5-10 parts of borneol and 50-80 parts of medical vaseline. The invention aims at providing the ointment which is capable of rapidly relieving pain and reducing swelling, and no scar is left after healing is finished.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to an ointment for treating burns and scalds. Background technique [0002] In people's daily life, accidents such as burns and scalds will inevitably occur, which will bring pain to people, especially after the injury leaves too many scars, which will bring greater pain to people mentally. At present, the medicines for treating burns and scalds on the market include dressings, water preparations, ointments, etc., but most of the medicines have unsatisfactory curative effects. Not only the treatment period is long, but also it is difficult to eliminate the scars left after healing. Contents of the invention [0003] The purpose of the present invention is to provide a kind of ointment that can quickly relieve pain, detumescence, and leave no scar after healing. [0004] The technical scheme adopted in the present invention is, a kind of ointment for treating burns and scalds, s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/815A61K9/06A61P17/02A61K31/045
Inventor 谭小毛
Owner 谭小毛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap